anti-TNF therapyadvanced therapiesanti-TNF-α therapyadalimumabrisankizumabvedolizumabustekinumabinfliximab
…rates of oesophagogastric and perianal disease. OFG responds to anti-TNF therapy in most cases, but may require escalated dosing. >60% of patien…